IP Library Granted Patent US 10,292,964
Granted Patent B2
US 10,292,964 · App. 14/271,242 · Granted May 21, 2019

Compositions for increasing human growth hormone levels

Inventors: Amy L. Heaton (Salt Lake City, UT); Mitchell K. Friedlander (Salt Lake City, UT); Dennis Gay (Salt Lake City, UT)
Assignee: Quality IP Holdings, LLC
A61K31/4015A61K31/198A61K31/401A61K36/538
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,292,964
App. No.
14/271,242
Granted
May 21, 2019
Kind
B2
Abstract

Embodiments of the invention generally relate to supplements for increasing human growth hormone (hGH) levels in healthy human beings.

Claims (20)

1. An oral nutritional supplement for increasing human growth hormone levels, comprising:

3.44 mmol L-arginine;

5.30 mmol Oxo-proline;

8.21 mmol L-lysine;

6.13 μmol N-acetyl L-cysteine;

6.84 μmol L-glutamine; and

0.50 mg Schizonepta (aerial parts) powder,

wherein at least one of the L-arginine, the oxo-proline, the L-lysine, the cysteine, the N-acetyl L-cysteine, or the glutamine is in the form of non-toxic salts thereof, stable chelates thereof, active esters thereof, or mixtures thereof.

2. The supplement of claim 1 , wherein the nutritional supplement is present in an amount of 2.9 grams.

3. The supplement of claim 1 , wherein the nutritional supplement is in powder, tablet, capsule, liquid, or wafer form.

4. An oral nutritional supplement for increasing human growth hormone levels, comprising:

725.50 mg L-arginine HCl;

683.70 mg L-pyroglutamic acid;

1499.30 mg L-lysine HCl;

1.00 mg N-acetyl L-cysteine USP;

1.00 mg L-glutamine; and

0.50 mg Schizonepta (aerial parts) powder,

wherein at least one of the L-arginine, the oxo-proline, the L-lysine, the cysteine, or the glutamine is in the form of non-toxic salts thereof, stable chelates thereof, active esters thereof, or mixtures thereof.

5. The supplement of claim 4 , wherein the nutritional supplement is present in an amount of 2.9 grams.

6. The supplement of claim 4 , wherein the nutritional supplement is in powder, tablet, capsule, liquid, or wafer form.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Jan 5, 2023
From: CASPAR CAPITAL LP
To: QUALITY IP HOLDINGS LLC
Reel/Frame 062283/0073 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2022
From: CERBERUS BUSINESS FINANCE, LLC
To: CASPAR CAPITAL LP
Reel/Frame 061636/0625 →
ASSIGNMENT OF SECURITY INTEREST Recorded Dec 30, 2019
From: LS2, LLC
To: CERBERUS BUSINESS FINANCE, LLC
Reel/Frame 051447/0114 →
SECURITY INTEREST Recorded Aug 21, 2015
From: QUALITY IP HOLDINGS, LLC
To: LS2, LLC
Reel/Frame 036392/0053 →
ASSIGNMENT FOR SECURITY - PATENTS Recorded Dec 4, 2014
From: QUALITY IP HOLDINGS, LLC
To: CERBERUS BUSINESS FINANCE, LLC, AS COLLATERAL AGENT
Reel/Frame 034535/0294 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2014
From: HEATON, AMY L.; FRIEDLANDER, MITCHELL K.; GAY, DENNIS
To: QUALITY IP HOLDINGS, LLC
Reel/Frame 033499/0629 →
Continuity (2)
Continuation 13623117 · Sep 20, 2012
Related Publication 20140242201A1 · Aug 28, 2014